1. Home
  2. BBD vs IQV Comparison

BBD vs IQV Comparison

Compare BBD & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Bradesco Sa

BBD

Banco Bradesco Sa

N/A

Current Price

$3.69

Market Cap

36.3B

Sector

Finance

ML Signal

N/A

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$235.80

Market Cap

35.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBD
IQV
Founded
1943
1982
Country
Brazil
United States
Employees
80348
93000
Industry
Major Banks
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3B
35.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BBD
IQV
Price
$3.69
$235.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
16
Target Price
N/A
$227.13
AVG Volume (30 Days)
33.3M
1.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
4.82%
N/A
EPS Growth
N/A
4.67
EPS
N/A
1.61
Revenue
N/A
$9,739,000,000.00
Revenue This Year
$70.86
$6.77
Revenue Next Year
$8.33
$5.89
P/E Ratio
$9.20
$132.43
Revenue Growth
N/A
41.60
52 Week Low
$2.73
$154.50
52 Week High
$4.30
$247.05

Technical Indicators

Market Signals
Indicator
BBD
IQV
Relative Strength Index (RSI) 58.03 78.92
Support Level $3.41 $220.85
Resistance Level $3.74 $245.60
Average True Range (ATR) 0.07 6.02
MACD 0.01 1.47
Stochastic Oscillator 81.22 97.45

Price Performance

Historical Comparison
BBD
IQV

About BBD Banco Bradesco Sa

Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation, a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: